Medicine & Life Sciences
Galactosylceramides
100%
Oligodeoxyribonucleotides
93%
Natural Killer T-Cells
92%
HIV-1
66%
GP 140
62%
Vaccination
61%
Immunization
43%
Vaccines
28%
Proteins
28%
gp140 envelope protein, Human immunodeficiency virus 1
24%
T-Lymphocytes
23%
Mucous Membrane
20%
alpha-galactosylceramide
19%
Mouth Floor
16%
Antigens
16%
Immunoglobulin A
11%
Serum
11%
Antibody Formation
11%
HIV Infections
11%
Mouth
10%
Immunoglobulin G
9%
Safety
7%
Antibodies
7%
Agriculture & Biology
natural killer cells
96%
Human immunodeficiency virus 1
94%
adjuvants
80%
agonists
71%
T-lymphocytes
70%
vaccination
69%
immunization
50%
vaccines
33%
antigens
28%
proteins
25%
immune response
21%
mouth
19%
neutralization
13%
antibody formation
12%
mucosa
12%
antibodies
8%
mice
7%
infection
6%
tissues
5%
Social Sciences
vaccination
85%
neutralization
25%
contact
13%